Role of cyclo-oxygenase-2 induction in interleukin-1β induced attenuation of cultured human airway smooth muscle cell cyclic AMP generation in response to isoprenaline
Open Access
- 1 November 1998
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 125 (6) , 1320-1328
- https://doi.org/10.1038/sj.bjp.0702193
Abstract
1 Airway smooth muscle (ASM) in human asthma shows reduced relaxation and cyclic AMP generation in response to β‐adrenoceptor agonists. IL‐β attenuates cyclic AMP generation but the underlying mechanism is unclear. We have reported that IL‐1β induces cyclo‐oxygenase‐2 (COX‐2) in human ASM cells and results in a marked increase in prostanoid generation with PGE2 and PGI2 as the major products. 2 We investigated the role of COX‐2 induction and prostanoid release (measured as PGE2) in IL‐1β induced attenuation of cyclic AMP generation in response to the β‐adrenoceptor agonist isoprenaline (ISO). 3 Pre‐treatment of human ASM cells with IL‐1β significantly attenuated cyclic AMP generation in response to high concentrations of ISO (1.0–10.0 μm) in a time‐ and concentration‐dependent manner. The effect was accompanied by a high concentration of PGE2 release. The non‐selective COX inhibitor indomethacin (Ind), the selective COX‐2 inhibitor NS‐398, the protein synthesis inhibitors cycloheximide (CHX) and actinomycin D and the steroid dexamethasone (Dex) all abolished the PGE2 release and prevented the attenuated cyclic AMP generation. 4 COX substrate arachidonic acid time‐ and concentration‐dependently mimicked IL‐1β induced attenuation and the effect was prevented by the non‐selective COX inhibitors Ind and flurbiprofen, but not by NS‐398, CHX and Dex. 5 In contrast to IL‐1β, TNFα and IFNγ, which are ineffective in inducing COX‐2 and releasing PGE2 from human ASM cells, did not affect the cyclic AMP formation. 6 Our study demonstrates that COX‐2 induction and the consequent release of prostanoids plays a crucial role in IL‐1β induced attenuation of human ASM cell cyclic AMP response to ISO. British Journal of Pharmacology (1998) 125, 1320–1328; doi:10.1038/sj.bjp.0702193Keywords
This publication has 28 references indexed in Scilit:
- Beta-adrenergic receptors and their regulation.American Journal of Respiratory and Critical Care Medicine, 1995
- Production of PGE2 by bovine cultured airway smooth muscle cells and its inhibition by cyclo‐oxygenase inhibitorsBritish Journal of Pharmacology, 1994
- Impaired β-adrenergic Receptor Activation of Adenylyl Cyclase in Airway Smooth Muscle in the Basenji-Greyhound Dog Model of Airway HyperresponsivenessAmerican Journal of Respiratory Cell and Molecular Biology, 1993
- β 2-Adrenoceptor desensitization in cultured human airway smooth muscleClinical Science, 1993
- Elevated Release of Tumor Necrosis Factor-alpha and Interferon-gamma by Bronchoalveolar Leukocytes from Patients with Bronchial AsthmaAmerican Review of Respiratory Disease, 1993
- Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cellsBritish Journal of Pharmacology, 1992
- Tumor Necrosis Factor Causes Bronchial Hyperresponsiveness in RatsAmerican Review of Respiratory Disease, 1992
- Abnormalities in Airway Smooth Muscle in Fatal Asthma: A Comparison between Trachea and BronchusAmerican Review of Respiratory Disease, 1991
- Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction.Circulation Research, 1990
- In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta‐adrenoceptor agonists and theophylline.British Journal of Clinical Pharmacology, 1986